| Dr Mary Katherine Moring, OD | |
|
2800 Ross Clark Cir, Dothan, AL 36301-2040 | |
| (334) 793-2211 | |
| Not Available |
| Full Name | Dr Mary Katherine Moring |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 11 Years |
| Location | 2800 Ross Clark Cir, Dothan, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578995197 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | S-D02-TA-954 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eye Partners Pc | 8123016334 | 24 |
News Archive
Surgical patients who demonstrated heightened pain sensitivity, or hyperalgesia, induced by high doses of a synthetic opioid had their symptoms alleviated by co-treatment with dexmedetomidine, according to new research. Study investigators, who presented their results today at the 29th Annual Meeting of the American Academy of Pain Medicine, concluded that dexmedetomidine may be a new and effective treatment option for opioid-induced hyperalgesia (OIH).
Researchers should include laboratory mice that are old and obese in their studies of immunotherapy treatments for cancer, according to a review article by Saint Louis University scientists.
Pancreatic ductal adenocarcinoma is a highly malignant digestive tumor with a very poor prognosis. Hypoxia-inducible transcription factor-1α is involved in malignant progression in many solid tumors, including PDAC, upregulation of HIF-1α accelerates PDAC progression, but the exact regulatory mechanisms of HIF-1αin PDAC has not been unequivocally addressed.
Researchers at the University of Michigan Comprehensive Cancer Center have discovered two cancer-spurring gene rearrangements that may trigger 5 to 7 percent of all breast cancers.
› Verified 7 days ago
| Provider Name | Eye Partners Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1902837453 PECOS PAC ID: 8123016334 Enrollment ID: O20050912000987 |
News Archive
Surgical patients who demonstrated heightened pain sensitivity, or hyperalgesia, induced by high doses of a synthetic opioid had their symptoms alleviated by co-treatment with dexmedetomidine, according to new research. Study investigators, who presented their results today at the 29th Annual Meeting of the American Academy of Pain Medicine, concluded that dexmedetomidine may be a new and effective treatment option for opioid-induced hyperalgesia (OIH).
Researchers should include laboratory mice that are old and obese in their studies of immunotherapy treatments for cancer, according to a review article by Saint Louis University scientists.
Pancreatic ductal adenocarcinoma is a highly malignant digestive tumor with a very poor prognosis. Hypoxia-inducible transcription factor-1α is involved in malignant progression in many solid tumors, including PDAC, upregulation of HIF-1α accelerates PDAC progression, but the exact regulatory mechanisms of HIF-1αin PDAC has not been unequivocally addressed.
Researchers at the University of Michigan Comprehensive Cancer Center have discovered two cancer-spurring gene rearrangements that may trigger 5 to 7 percent of all breast cancers.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mary Katherine Moring, OD 2800 Ross Clark Cir, Dothan, AL 36301-2040 Ph: (334) 793-2211 | Dr Mary Katherine Moring, OD 2800 Ross Clark Cir, Dothan, AL 36301-2040 Ph: (334) 793-2211 |
News Archive
Surgical patients who demonstrated heightened pain sensitivity, or hyperalgesia, induced by high doses of a synthetic opioid had their symptoms alleviated by co-treatment with dexmedetomidine, according to new research. Study investigators, who presented their results today at the 29th Annual Meeting of the American Academy of Pain Medicine, concluded that dexmedetomidine may be a new and effective treatment option for opioid-induced hyperalgesia (OIH).
Researchers should include laboratory mice that are old and obese in their studies of immunotherapy treatments for cancer, according to a review article by Saint Louis University scientists.
Pancreatic ductal adenocarcinoma is a highly malignant digestive tumor with a very poor prognosis. Hypoxia-inducible transcription factor-1α is involved in malignant progression in many solid tumors, including PDAC, upregulation of HIF-1α accelerates PDAC progression, but the exact regulatory mechanisms of HIF-1αin PDAC has not been unequivocally addressed.
Researchers at the University of Michigan Comprehensive Cancer Center have discovered two cancer-spurring gene rearrangements that may trigger 5 to 7 percent of all breast cancers.
› Verified 7 days ago
Murray Vision Source Inc Optometrist Medicare: Medicare Enrolled Practice Location: 550 John D Odom Rd, Dothan, AL 36303 Phone: 334-699-5999 Fax: 334-479-0631 | |
Dr. Michael Joel Hill, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4310 Montgomery Hwy, Dothan, AL 36303 Phone: 334-671-9719 Fax: 334-671-9721 | |
Jordan Johnson, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2800 Ross Clark Cir, Dothan, AL 36301 Phone: 334-792-2211 | |
Dr. William H Feagin, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 111 W Main St, Dothan, AL 36301 Phone: 334-794-1175 Fax: 334-793-0619 | |
Mr. David Walker Badham, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 151 W Main St, Dothan, AL 36301 Phone: 334-793-2633 Fax: 334-794-1626 | |
Dr. Lauren Elise Albert, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 200 Medical Care Way, Dothan, AL 36303 Phone: 334-794-8797 Fax: 334-479-0658 | |
Paul Curtis Roten, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1936 Ross Clark Cir, Dothan, AL 36301 Phone: 334-794-0585 Fax: 337-671-4943 |